823 related articles for article (PubMed ID: 18292929)
1. Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review).
Hoskin DW; Mader JS; Furlong SJ; Conrad DM; Blay J
Int J Oncol; 2008 Mar; 32(3):527-35. PubMed ID: 18292929
[TBL] [Abstract][Full Text] [Related]
2. Adenosine acts through a novel extracellular receptor to inhibit granule exocytosis by natural killer cells.
Williams BA; Manzer A; Blay J; Hoskin DW
Biochem Biophys Res Commun; 1997 Feb; 231(2):264-9. PubMed ID: 9070261
[TBL] [Abstract][Full Text] [Related]
3. 2-chloroadenosine stimulates granule exocytosis from mouse natural killer cells: evidence for signal transduction through a novel extracellular receptor.
Williams BA; Blay J; Hoskin DW
Exp Cell Res; 1997 May; 233(1):187-97. PubMed ID: 9184087
[TBL] [Abstract][Full Text] [Related]
4. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
5. Purine metabolites suppress proliferation of human NK cells through a lineage-specific purine receptor.
Miller JS; Cervenka T; Lund J; Okazaki IJ; Moss J
J Immunol; 1999 Jun; 162(12):7376-82. PubMed ID: 10358189
[TBL] [Abstract][Full Text] [Related]
6. Adenosine acts through an A3 receptor to prevent the induction of murine anti-CD3-activated killer T cells.
Hoskin DW; Butler JJ; Drapeau D; Haeryfar SM; Blay J
Int J Cancer; 2002 May; 99(3):386-95. PubMed ID: 11992407
[TBL] [Abstract][Full Text] [Related]
7. NK cell receptors as tools in cancer immunotherapy.
Sentman CL; Barber MA; Barber A; Zhang T
Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660
[TBL] [Abstract][Full Text] [Related]
8. T-cell adoptive therapy of tumors: mechanisms of improved therapeutic performance.
Cohen PA; Peng L; Kjaergaard J; Plautz GE; Finke JH; Koski GK; Czerniecki BJ; Shu S
Crit Rev Immunol; 2001; 21(1-3):215-48. PubMed ID: 11642606
[TBL] [Abstract][Full Text] [Related]
9. 2-Chloroadenosine inhibits the MHC-unrestricted cytolytic activity of anti-CD3-activated killer cells: evidence for the involvement of a non-A1/A2 cell-surface adenosine receptor.
Hoskin DW; Reynolds T; Blay J
Cell Immunol; 1994 Nov; 159(1):85-93. PubMed ID: 7954843
[TBL] [Abstract][Full Text] [Related]
10. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
Borg C; Taieb J; Terme M; Maruyama K; Flament C; Angevin E; Zitvogel L
Bull Cancer; 2003; 90(8-9):699-705. PubMed ID: 14609759
[TBL] [Abstract][Full Text] [Related]
11. Innate immune recognition and suppression of tumors.
Hayakawa Y; Smyth MJ
Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661
[TBL] [Abstract][Full Text] [Related]
12. Tumor-host immune interactions and dendritic cell dysfunction.
Yang L; Carbone DP
Adv Cancer Res; 2004; 92():13-27. PubMed ID: 15530555
[TBL] [Abstract][Full Text] [Related]
13. MHC class I antigens, immune surveillance, and tumor immune escape.
Garcia-Lora A; Algarra I; Garrido F
J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644
[TBL] [Abstract][Full Text] [Related]
14. Adenosine-mediated inhibition of the cytotoxic activity and cytokine production by activated natural killer cells.
Lokshin A; Raskovalova T; Huang X; Zacharia LC; Jackson EK; Gorelik E
Cancer Res; 2006 Aug; 66(15):7758-65. PubMed ID: 16885379
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of CD40L and CD70 by semiallogenic tumor cells induces anti-tumor immunity.
Cormary C; Hiver E; Mariamé B; Favre G; Tilkin-Mariamé AF
Cancer Gene Ther; 2005 Dec; 12(12):963-72. PubMed ID: 15956983
[TBL] [Abstract][Full Text] [Related]
16. IL-15: targeting CD8+ T cells for immunotherapy.
Diab A; Cohen AD; Alpdogan O; Perales MA
Cytotherapy; 2005; 7(1):23-35. PubMed ID: 16040381
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory T cells in tumor immunity.
Terabe M; Berzofsky JA
Curr Opin Immunol; 2004 Apr; 16(2):157-62. PubMed ID: 15023407
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor.
Ohana G; Bar-Yehuda S; Barer F; Fishman P
J Cell Physiol; 2001 Jan; 186(1):19-23. PubMed ID: 11147810
[TBL] [Abstract][Full Text] [Related]
19. Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.
MacKenzie WM; Hoskin DW; Blay J
Exp Cell Res; 2002 May; 276(1):90-100. PubMed ID: 11978011
[TBL] [Abstract][Full Text] [Related]
20. A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion.
Check JH; Nazari P; Goldberg J; Yuen W; Angotti D
Med Hypotheses; 2001 Sep; 57(3):337-43. PubMed ID: 11516226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
